Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Role of bone marrow biopsy for fever of unknown origin in the contemporary Australian context

Hong FS, Fox LC, Chai KL, Htun K, Clucas D, Morgan S, Cole-Sinclair MF, Juneja S

(2019), Intern Med J, 49(7), 850-4

DOI: 10.1111/imj.14147

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma

Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Navarro JT, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M

(2019), Brit J Haematol, 184(4), 679-82

DOI: 10.1111/bjh.15156

Increasing Understanding Regarding the Risk of Concomitant Use of Carbamazepine and Direct Oral Anticoagulants

Bortz H, Corallo CE, Tran H

(2019), J Pharm Pract, 32(2), 123-5

DOI: 10.1177/0897190018786837

New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism

Tran HA, Gibbs H, Merriman E, Curnow JL, Young L, Bennett A, Wee TC, Chunilal SD, Ward CM, Baker R, Nandurkar H

(2019), MED J AUSTRALIA, 210(5), 227-35

DOI: 10.5694/mja2.50004

Misinterpretation of blood group and antibody screen leading to serious errors in RhD immunoglobulin administration: A report on first two years of data from Serious Transfusion Incident Reporting program

Akers C, Savoia H, Kane S, Crispin P, Keegan A, Wood E, Glazebrook B, Bielby L, Davis AK

(2019), AUST NZ J OBSTET GYN, 59(1), 161-4

DOI: 10.1111/ajo.12889

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

Horvath N, Spencer A, Kenealy M, Joshua D, Campbell PJ, Lee JJ, Hou J, Qiu L, Kalff A, Khong T, Londhe A, Siggins S, van Kooten Losio M, Eisbacher M, Prince HM

(2019), LEUKEMIA LYMPHOMA, 60(9), 2122-33

DOI: 10.1080/10428194.2019.1579322

Pirfenidone causes false-positive urine benzodiazepine results: Implications for patients with pulmonary fibrosis

Pope JD, Drummer OH, Schneider HG

(2018), J Heart Lung Transplant, 37(12),

DOI: 10.1016/j.healun.2018.09.014

The cocaine cutting agent levamisole is frequently detected in cocaine users

Pope JD, Drummer OH, Schneider HG

(2018), Pathology, 50(5),

DOI: 10.1016/j.pathol.2018.03.006

How does a high sensitivity cardiac troponin I assay help us when patients with chronic renal failure present to the emergency department?

Schneider HG

(2018), J Lab Precis Med, 3,

DOI: 10.21037/jlpm.2018.03.08

Misclassification of Calcium Status Based on Albumin-Adjusted Calcium: Studies in a Tertiary Hospital Setting

Smith JD, Wilson S, Schneider HG

(2018), Clin Chem, 64(12),

DOI: 10.1373/clinchem.2018.291377

Novel Benzodiazepines (Clonazolam and Flubromazolam) Identified in Candy-Like Pills

Jeffrey D. Pope, Kay Weng Choy, Olaf H. Drummer, Hans G. Schneider

(2018), J Appl Lab Med, 3(1),

DOI: 10.1373/jalm.2017.025387

Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole in human plasma using LCMS/MS

Jenkins N, Black M, Schneider HG

(2018), Clin Biochem, 53,

DOI: 10.1016/j.clinbiochem.2018.01.004

Rapid and safe discharge from the emergency department: A single troponin to exclude acute myocardial infarction

Brichko L, Schneider HG, Chan W, Seah J, Smit V, Dart A, Stevens JP, Mitra B

(2018), Emerg Med Australas, 30(4),

DOI: 10.1111/1742-6723.12919

A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum

Smith J, Raines G, Schneider HG

(2018), Clin Chem Lab Med, 56(2),

DOI: 10.1515/cclm-2017-0266

Time to repeal and replace response criteria for acute myeloid leukemia?

Bloomfield CD, Estey E, Pleyer L, Schuh AC, Stein EM, Tallman MS, Wei A

(2018), Blood Rev, 32(5), 416-425

DOI: 10.1016/j.blre.2018.03.006

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies

Caenepeel S, Brown SP, Belmontes B, Moody G, Keegan KS, Chui D, Whittington DA, Huang X, Poppe L, Cheng AC, Cardozo M, Houze J, Li Y, Lucas B, Paras NA, Wang X, Taygerly JP, Vimolratana M, Zancanella M, Zhu L, Cajulis E, Osgood T, Sun J, Damon L, Egan RK, Greninger P, McClanaghan JD, Gong J, Moujalled D, Pomilio G, Beltran P, Benes CH, Roberts AW, Huang DC, Wei A, Canon J, Coxon A, Hughes PE

(2018), Cancer Discov, 8(12), 1582-1597

DOI: 10.1158/2159-8290.CD-18-0387

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

DiNardo CD, Pratz KW, Letai A, Jonas BA, Wei AH, Thirman M, Arellano M, Frattini MG, Kantarjian H, Popovic R, Chyla B, Xu T, Dunbar M, Agarwal SK, Humerickhouse R, Mabry M, Potluri J, Konopleva M, Pollyea DA

(2018), Lancet Oncol, 19(2), 216-228

DOI: 10.1016/S1470-2045(18)30010-X

Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML

Duarte D, Hawkins ED, Akinduro O, Ang H, De Filippo K, Kong IY, Haltalli M, Ruivo N, Straszkowski L, Vervoort SJ, McLean C, Weber TS, Khorshed R, Pirillo C, Wei A, Ramasamy SK, Kusumbe AP, Duffy K, Adams RH, Purton LE, Carlin LM, Lo Celso C

(2018), Cell Stem Cell, 22(1), 64-77

DOI: 10.1016/j.stem.2017.11.006

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines

Merino D, Kelly GL, Lessene G, Wei AH, Roberts AW, Strasser A

(2018), Cancer Cell, 34(6), 879-891

DOI: 10.1016/j.ccell.2018.11.004

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

Teh TC, Nguyen NY, Moujalled DM, Segal D, Pomilio G, Rijal S, Jabbour A, Cummins K, Lackovic K, Blombery P, Thompson E, Ekert PG, Lessene G, Glaser SP, Huang DCS, Roberts AW, Guthridge MA, Wei AH

(2018), Leukemia, 32(2), 303-312

DOI: 10.1038/leu.2017.243

7 8 9 10 11